Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Marker Therapeutics, Inc. (NASDAQ: MRKR)
MRKR Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
385.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
MRKR Stock Analysis
MRKR
PE Ratio:
MRKR
PEG Ratio:
Not Available
MRKR
Forward EPS Growth (12 month):
0.00%
MRKR
PS Ratio:
4.9
MRKR
PSG Ratio:
MRKR
Forward Revenue Growth (12 month):
400.00%
MRKR Articles
No data was found